drugset
drugset / Trial / NCT03800550

A Study to Assess the Drug-Drug Interaction Between Bedaquiline and Clarithromycin in Healthy Adult Participants

NCT03800550 ↗

Phase 1 Completed 16 enrolled Janssen Research & Development, LLC
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to assess the effect of steady-state clarithromycin once every 12 hour on the pharmacokinetic parameters of bedaquiline and its active metabolite M2 after a single dose of bedaquiline.

Timeline

Start
2019-02-13
Primary completion
2019-06-04
Completion
2019-06-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Bedaquiline Small molecule — Oral
Subject Clarithromycin Small molecule — Oral

Indications

No indication recorded.